close
close
migores1

GE HealthCare Technologies (NASDAQ:GEHC) vs Aclarion (NASDAQ:ACONW) Head to Head Contrast

Aclarion ( NASDAQ:ACONW – Get Free Report ) and GE HealthCare Technologies ( NASDAQ:GEHC – Get Free Report ) are both healthcare companies, but which is the better business? We’ll compare the two companies based on risk strength, institutional ownership, profitability, earnings, valuation, dividends and analyst recommendations.

Rating and Earnings

This table compares Aclarion and GE HealthCare Technologies’ gross revenue, earnings per share (EPS) and valuation.

Gross Income Price/sales ratio net income Earnings per share Price/earnings ratio
Aclarion $53,947.00 N/A N/A N/A N/A
GE Healthcare Technologies 19.52 billion dollars 1.98 1.57 billion dollars $3.42 24.80

GE HealthCare Technologies has higher revenue and earnings than Aclarion.

Analyst recommendations

Want more great investment ideas?

This is a summary of current recommendations for Aclarion and GE HealthCare Technologies as provided by MarketBeat.com.

Sales reviews Keep ratings Buy ratings Strong buy ratings Evaluation score
Aclarion 0 0 0 0 N/A
GE Healthcare Technologies 0 5 6 1 2.67

GE HealthCare Technologies has a consensus price target of $95.00, indicating a potential upside of 12.00%. Given GE HealthCare Technologies’ higher possible upside, analysts plainly believe GE HealthCare Technologies is more favorable than Aclarion.

return

This table compares Aclarion and GE HealthCare Technologies’ net margins, return on equity and return on assets.

Net margins Return on equity Return on assets
Aclarion N/A N/A N/A
GE Healthcare Technologies 8.10% 25.26% 5.79%

Insider and institutional ownership

82.1% of GE HealthCare Technologies shares are owned by institutional investors. 0.3% of GE HealthCare Technologies shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and big money managers believe a company will outperform the market over the long term.

Summary

GE HealthCare Technologies beats Aclarion in 9 of the 9 factors compared between the two stocks.

About Aclarion

(Get a free report)

Aclarion, Inc., a medical technology company, uses magnetic resonance spectroscopy (MRS) in the United States. She develops the NOCISCAN Post-Processor suite of software applications comprising NOCICALC which receives raw NOCISCAN MRS exam data and post-processes the raw data into final spectra and performs various degenerative pain biomarkers; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is headquartered in Broomfield, Colorado.

About GE HealthCare Technologies

(Get a free report)

GE Healthcare Technologies Inc. engages in the development, manufacture and marketing of complementary digital products, services and solutions used in the diagnosis, treatment and monitoring of patients in the United States, Canada and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions and Pharmaceutical Diagnostics. The imaging segment offers molecular imaging, computed tomography (CT), magnetic resonance imaging (MRI), image-guided therapy, X-ray systems and women’s health products. The Ultrasound segment provides medical devices and solutions for the screening, diagnosis, treatment and monitoring of certain diseases in clinical areas such as radiology and primary care, women’s health, cardiovascular and point-of-care portable ultrasound solutions, as well as surgical visualization. and guidance products. The Patient Care Solutions segment offers medical devices, supplies, services and digital solutions. Its portfolio includes patient monitoring solutions, anesthesia and respiratory care products, electrocardiogram solutions, maternal infant care products and supplies and services. Pharmaceutical Diagnostics provides diagnostic agents including CT, angiography and X-ray, MR, single photon emission computed tomography, positron emission tomography and ultrasound to the radiology and nuclear medicine industries. The segment also offers contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging examinations; and molecular imaging agents or radiopharmaceuticals, which are radioisotope-labeled molecular tracers. It has an AI collaboration with Mass General Brigham. The company was previously known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was founded in 2022 and is headquartered in Chicago, Illinois.

Get news and reviews for Aclarion Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Aclarion and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Articles

Back to top button